Alan F. Denenberg

Davis Polk is advising J.P. Morgan Securities LLC and Citigroup Global Markets Inc. as financial advisers to Rockwell Collins, Inc. in connection with its $23 billion merger with United…

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $500 million aggregate…

Davis Polk advised the manager and the global structuring agent and coordinator in connection with Intel’s SEC-registered offering in Taiwan of $640 million aggregate principal…

Davis Polk advised Accuray Incorporated in connection with a private exchange of approximately $47 million aggregate principal amount of its outstanding 3.50% convertible senior notes due…

Davis Polk advised Equinix, Inc. in connection with its SEC-registered at-the-market offering of its shares of common stock for up to an aggregate amount of $750 million.  Equinix, Inc…

Davis Polk is advising TerraVia Holdings, Inc. in connection with its restructuring under chapter 11 of the U.S. Bankruptcy Code, entry into a “stalking horse” stock and asset purchase…

Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of Sienna Biopharmaceuticals, Inc., including shares sold pursuant to…

Davis Polk advised the underwriters in connection with an initial public offering of 17,968,750 shares of common stock of Akcea Therapeutics, Inc., including shares sold pursuant to the…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Bankrate, Inc. in connection with its acquisition at an enterprise value of approximately $1.4 billion by Red…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with its acquisition by a wholly owned subsidiary of Royal Philips,…